Trials / Sponsors / John Levine
John Levine
Academic / Other · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | MAGIC Ruxolitinib for aGVHD Acute Graft-versus-host Disease, Allogeneic Bone Marrow Transplantation, Adverse Effects | Phase 2 | 2025-05-14 |
| Active Not Recruiting | Pediatric GVHD Low Risk Steroid Taper Trial Acute Graft vs Host Disease, Allogeneic Bone Marrow Transplantation, Adverse Effects | Phase 2 | 2022-10-20 |
| Completed | Itacitinib for Low Risk GVHD Low Risk Acute Graft-versus-host Disease, Graft-versus-host-disease, GVHD | Phase 2 | 2019-03-25 |
| Completed | A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD Graft-versus-host-disease, GVHD | Phase 2 | 2018-08-17 |
| Completed | Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease Acute Graft Versus Host Disease | Phase 2 | 2016-08-01 |